| Actilyse 10 mg powder and solvent for solution for injection and infusion PA0775/011/001 |
Alteplase |
Boehringer Ingelheim International GmbH |
Marketed |
| Actilyse 20 mg powder and solvent for solution for injection and infusion PA0775/011/002 |
Alteplase |
Boehringer Ingelheim International GmbH |
Marketed |
| Actilyse 50 mg powder and solvent for solution for injection and infusion PA0775/011/003 |
Alteplase |
Boehringer Ingelheim International GmbH |
Marketed |
| Actilyse Cathflo 2 mg powder for solution for injection and infusion PA0775/011/004 |
Alteplase |
Boehringer Ingelheim International GmbH |
Marketed |
| Aptivus EU/1/05/315/002 |
Tipranavir |
Boehringer Ingelheim International GmbH |
— |
| Aptivus 250 mg soft capsules EU/1/05/315/001 |
Tipranavir |
Boehringer Ingelheim International GmbH |
— |
| Atrovent 250 UDVs 250 micrograms/ 1ml Nebuliser Solution PA0775/012/002 |
Ipratropium bromide |
Boehringer Ingelheim International GmbH |
Marketed |
| Atrovent 500 UDVs, 500 micrograms/ 2ml Nebuliser Solution PA0775/012/003 |
Ipratropium bromide |
Boehringer Ingelheim International GmbH |
Marketed |
| Atrovent Inhaler CFC-Free 20 micrograms per metered dose pressurised inhalation solution PA0775/012/001 |
Ipratropium bromide |
Boehringer Ingelheim International GmbH |
Not marketed |
| GIOTRIF 20 mg film-coated tablets EU/1/13/879/001-003 |
Afatinib-dimaleate |
Boehringer Ingelheim International GmbH |
— |
| GIOTRIF 30 mg film-coated tablets EU/1/13/879/004-006 |
Afatinib-dimaleate |
Boehringer Ingelheim International GmbH |
— |
| GIOTRIF 40 mg film-coated tablets EU/1/13/879/007-009 |
Afatinib-dimaleate |
Boehringer Ingelheim International GmbH |
— |
| GIOTRIF 50 mg film-coated tablets EU/1/13/879/010-012 |
Afatinib-dimaleate |
Boehringer Ingelheim International GmbH |
— |
| Glyxambi 10 mg/5 mg film-coated tablets EU/1/16/1146/001-009 |
Empagliflozin, Linagliptin |
Boehringer Ingelheim International GmbH |
— |
| Glyxambi 25 mg/5 mg film-coated tablets EU/1/16/1146/010-018 |
Empagliflozin, Linagliptin |
Boehringer Ingelheim International GmbH |
— |
| Jardiance 10 mg film-coated tablets EU/1/14/930/010-018 |
Empagliflozin |
Boehringer Ingelheim International GmbH |
— |
| Jardiance 25 mg film-coated tablets EU/1/14/930/001-009 |
Empagliflozin |
Boehringer Ingelheim International GmbH |
— |
| Jentadueto 2.5 mg/1000 mg film-coated tablets EU/1/12/780/015-028 |
Metformin, Linagliptin |
Boehringer Ingelheim International GmbH |
— |
| Jentadueto 2.5 mg/850 mg film-coated tablets EU/1/12/780/001-014 |
Linagliptin, Metformin |
Boehringer Ingelheim International GmbH |
— |
| Metalyse 10 000 units (50 mg) powder and solvent for solution for injection EU/1/00/169/006 |
Tenecteplase |
Boehringer Ingelheim International GmbH |
— |
| Metalyse 25mg Powder for solution for injection EU/1/00/169/007 |
Tenecteplase |
Boehringer Ingelheim International GmbH |
— |
| Metalyse 8 000 units (40 mg) powder and solvent for solution for injection EU/1/00/169/005 |
Tenecteplase |
Boehringer Ingelheim International GmbH |
— |
| Micardis 20 mg tablets EU/1/98/090/009-012 |
Telmisartan |
Boehringer Ingelheim International GmbH |
— |
| Micardis 40 mg tablets EU/1/98/090/001-004 |
Telmisartan |
Boehringer Ingelheim International GmbH |
— |
| Micardis 80 mg tablets EU/1/98/090/005-008 |
Telmisartan |
Boehringer Ingelheim International GmbH |
— |
| MicardisPlus 40 mg/12.5 mg tablets EU/1/02/213/001-005 |
Telmisartan, Hydrochlorothiazide |
Boehringer Ingelheim International GmbH |
— |
| MicardisPlus 80 mg/12.5 mg tablets EU/1/02/213/006-010 |
Telmisartan, Hydrochlorothiazide |
Boehringer Ingelheim International GmbH |
— |
| MicardisPlus 80 mg/25 mg tablets EU/1/02/213/17-23 |
Telmisartan, Hydrochlorothiazide |
Boehringer Ingelheim International GmbH |
— |
| MIRAPEXIN 0.088 mg tablets EU/1/97/051/001-002 |
Pramipexole dihydrochloride monohydrate |
Boehringer Ingelheim International GmbH |
— |
| MIRAPEXIN 0.18 mg tablets EU/1/97/051/003-004 |
Pramipexole dihydrochloride monohydrate |
Boehringer Ingelheim International GmbH |
— |
| MIRAPEXIN 0.26 mg prolonged-release tablets EU/1/97/051/13-15 |
Pramipexole dihydrochloride monohydrate |
Boehringer Ingelheim International GmbH |
— |
| MIRAPEXIN 0.35 mg tablets EU/1/97/051/011-012 |
Pramipexole dihydrochloride monohydrate |
Boehringer Ingelheim International GmbH |
— |
| MIRAPEXIN 0.52 mg prolonged-release tablets EU/1/97/051/16-18 |
Pramipexole dihydrochloride monohydrate |
Boehringer Ingelheim International GmbH |
— |
| MIRAPEXIN 0.7 mg tablets EU/1/97/051/005-006 |
Pramipexole dihydrochloride monohydrate |
Boehringer Ingelheim International GmbH |
— |
| MIRAPEXIN 1.05 mg prolonged-release tablets EU/1/97/051/19-21 |
Pramipexole dihydrochloride monohydrate |
Boehringer Ingelheim International GmbH |
— |
| MIRAPEXIN 1.57 mg prolonged-release tablets EU/1/97/051/028-30 |
Pramipexole dihydrochloride monohydrate |
Boehringer Ingelheim International GmbH |
— |
| MIRAPEXIN 2.1 mg prolonged-release tablets EU/1/97/051/22-24 |
Pramipexole dihydrochloride monohydrate |
Boehringer Ingelheim International GmbH |
— |
| MIRAPEXIN 2.62 mg prolonged-release tablets EU/1/97/051/031-33 |
Pramipexole dihydrochloride monohydrate |
Boehringer Ingelheim International GmbH |
— |
| MIRAPEXIN 3.15 mg prolonged-release tablets EU/1/97/051/25-27 |
Pramipexole dihydrochloride monohydrate |
Boehringer Ingelheim International GmbH |
— |
| Ofev 100 mg Soft capsule EU/1/14/979/001-002 |
Nintedanib |
Boehringer Ingelheim International GmbH |
— |
| Ofev 150 mg Soft capsule EU/1/14/979/003-004 |
Nintedanib |
Boehringer Ingelheim International GmbH |
— |
| Ofev 25mg Soft capsule EU/1/14/979/009-012 |
Nintedanib esylate |
Boehringer Ingelheim International GmbH |
— |
| Pradaxa 110 mg coated granules EU/1/08/442/0029 |
Dabigatran etexilate mesilate |
Boehringer Ingelheim International GmbH |
— |
| Pradaxa 110 mg hard capsules EU/1/08/442/5-8 |
Dabigatran etexilate |
Boehringer Ingelheim International GmbH |
— |
| Pradaxa 150 mg coated granules EU/1/08/442/030 |
Dabigatran etexilate mesilate |
Boehringer Ingelheim International GmbH |
— |
| Pradaxa 150 mg hard capsules EU/1/08/442/009-013 |
Dabigatran etexilate mesilate |
Boehringer Ingelheim International GmbH |
— |
| Pradaxa 20 mg coated granules EU/1/08/442/025 |
Dabigatran etexilate mesilate |
Boehringer Ingelheim International GmbH |
— |
| Pradaxa 30 mg coated granules EU/1/08/442/0026 |
Dabigatran etexilate mesilate |
Boehringer Ingelheim International GmbH |
— |
| Pradaxa 40 mg coated granules EU/1/08/442/0027 |
Dabigatran etexilate mesilate |
Boehringer Ingelheim International GmbH |
— |
| Pradaxa 50 mg coated granules EU/1/08/442/028 |
Dabigatran etexilate mesilate |
Boehringer Ingelheim International GmbH |
— |